Springer-Verlang. Vol.II, pp 217-235 (1991).
6. Woodruff, T.K., Regulation of cellular and system
function by activin. Biochem. Pharmacol., 55,
953-963 (1998).
7. Shoji, H., et al., Identification
Mason, A.J. et al., Structure of two human ovarian
inhibins. Biochem. Biophys. Res. Commun., 135,
957-964 (1986).
2. de Winter, J. et al., Activin is produced by rat Sertoli
cells in vitro and can
, A.J., et al., Structure of two human ovarian
inhibins. Biochem. Biophys. Res. Commun., 135,
957-964 (1986).
2. de Winter, J., et al., Activin is produced by rat
Sertoli cells in vitro and can
Mason, A.J., et al., Structure of two human
ovarian inhibins. Biochem. Biophys. Res.
Commun., 135, 957-964 (1986).
2. de Winter, J., et al., Activin is produced by rat
Sertoli cells in vitro and can
hepatocyte-like cells from the human hepatoma
HepaRG cell line through bipotent progenitor. Hepatology. 45 957-67 (2007).
http://www.ncbi.nlm.nih.gov/pubmed/17241619�
http://www.ncbi.nlm.nih.gov/pubmed
hepatocyte-like cells
from the human hepatoma HepaRG™ cell line through
bipotent progenitor. Hepatology 45, 957-67 (2007).
4. Marion MJ et al. The HepaRG™ cell line: biological
properties and relevance as a
µL 05-797
(Erk1/2)(Thr185/Tyr187)
Anti-MAP Kinase 1/Erk 1, CT M R IPK WB Pur Rb IgG 100 µL 05-957
Polyclonal Antibody
Anti-MAP Kinase 1/2 (Erk1/2), CT Av H M R IP WB IC APur Rb IgG 100
Ibrutinib: a first in class covalent inhibitor of Bruton’s tyrosine kinase. Future Oncol. 2014
May;10(6):957-67.
3. Bertacchini J, et al. Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in
IgG 100 µL 05-797
(Thr185/Tyr187)
Anti-MAP Kinase 1/Erk 1, CT M R IPK WB Pur Rb IgG 100 µL 05-957
Polyclonal Antibody
Anti-MAP Kinase 1/2 (Erk1/2), CT Av H M R IP WB IC APur Rb